Biopharmaceutical Manufacturing Preparedness-Consortium (BioMaP–Consortium)
Contact and place of performance
Shane Sarchiapone
Not specified
Note: Updated August 9, 2023 to add Amendment 1, which provides responses to questions regarding the solicitation. ------------------------------------------------------------------------------------------------------------------------ Biomedical Advanced Research and Development Authority's (BARDA) primary objective is to establish an agreement with a Consortium Management Firm (CMF) tasked to establish the BioMaP-C...
View moreThe Biomedical Advanced Research and Development Authority (BARDA), within the Office of the Assistant Secretary for Preparedness and Response, is seeking a Consortium Management Firm (CMF) to establish and manage the BioMaP-Consortium. Under the guidance of the BioMaP Branch of BARDA, the selected firm will oversee day-to-day operations, including all technical, programmatic, financial, and administrative matters. Key responsibilities involve soliciting, awarding, and managing project agreements and sub-agreements for consortium members. This initiative is categorized under NAICS 325414 for Biological Product (except Diagnostic) Manufacturing and PSC AN42 for Applied Research in Health R&D Services.
Solicitation 75A50123D00003 includes three attachments, such as a statement of objectives and a formal amendment issued on August 9, 2023, to address industry questions. Administrative inquiries were due by August 7, 2023, followed by a deadline for notices of intent on August 10, 2023. Final responses must be submitted electronically to the primary point of contact, Shane Sarchiapone, by 3:00 PM Eastern on August 22, 2023.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.